127 related articles for article (PubMed ID: 30926432)
1. Endothelin-converting enzyme-1 in cancer aggressiveness.
Tapia JC; Niechi I
Cancer Lett; 2019 Jun; 452():152-157. PubMed ID: 30926432
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion.
Lambert LA; Whyteside AR; Turner AJ; Usmani BA
Br J Cancer; 2008 Oct; 99(7):1114-20. PubMed ID: 18781169
[TBL] [Abstract][Full Text] [Related]
3. Effect of an antisense oligodeoxynucleotide to endothelin-converting enzyme-1c (ECE-1c) on ECE-1c mRNA, ECE-1 protein and endothelin-1 synthesis in bovine pulmonary artery smooth muscle cells.
Barker S; Khan NQ; Wood EG; Corder R
Mol Pharmacol; 2001 Feb; 59(2):163-9. PubMed ID: 11160849
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of endothelin-converting enzyme-1 in human prostate cancer.
Dawson LA; Maitland NJ; Berry P; Turner AJ; Usmani BA
Exp Biol Med (Maywood); 2006 Jun; 231(6):1106-10. PubMed ID: 16741058
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability.
Niechi I; Silva E; Cabello P; Huerta H; Carrasco V; Villar P; Cataldo LR; Marcelain K; Armisen R; Varas-Godoy M; Fernandez C; Tapia JC
Oncotarget; 2015 Dec; 6(40):42749-60. PubMed ID: 26543229
[TBL] [Abstract][Full Text] [Related]
6. The effects of phosphoramidon on the expression of human endothelin-converting enzyme-1 (ECE-1) isoforms.
Isaka D; Emoto N; Raharjo SB; Yokoyama M; Matsuo M
J Cardiovasc Pharmacol; 2003 Jul; 42(1):136-41. PubMed ID: 12827039
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-converting enzyme-1c promotes stem cell traits and aggressiveness in colorectal cancer cells.
Pérez-Moreno P; Indo S; Niechi I; Huerta H; Cabello P; Jara L; Aguayo F; Varas-Godoy M; Burzio VA; Tapia JC
Mol Oncol; 2020 Feb; 14(2):347-362. PubMed ID: 31788944
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells.
Keynan S; Khamaisi M; Dahan R; Barnes K; Jackson CD; Turner AJ; Raz I
J Vasc Res; 2004; 41(2):131-40. PubMed ID: 15010576
[TBL] [Abstract][Full Text] [Related]
9. Role of the hydrophobic transmembrane domain in membrane anchoring of endothelin-converting enzyme-1a.
Brooks SC; Ergul A
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S30-2. PubMed ID: 11078328
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells.
Hunter AR; Turner AJ
Exp Biol Med (Maywood); 2006 Jun; 231(6):718-22. PubMed ID: 16740987
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells.
Rayhman O; Klipper E; Muller L; Davidson B; Reich R; Meidan R
Cancer Res; 2008 Nov; 68(22):9265-73. PubMed ID: 19010899
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-2 synthesis is stimulated by the type-1 tumour necrosis factor receptor and cAMP: comparison with endothelin-converting enzyme-1 expression.
Lambert GL; Barker S; Lees DM; Corder R
J Mol Endocrinol; 2000 Apr; 24(2):273-83. PubMed ID: 10750028
[TBL] [Abstract][Full Text] [Related]
13. Endothelin system in oral squamous carcinoma cells: specific siRNA targeting of ECE-1 blocks cell proliferation.
Awano S; Dawson LA; Hunter AR; Turner AJ; Usmani BA
Int J Cancer; 2006 Apr; 118(7):1645-52. PubMed ID: 16217751
[TBL] [Abstract][Full Text] [Related]
14. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations.
Schweizer A; Valdenaire O; Nelböck P; Deuschle U; Dumas Milne Edwards JB; Stumpf JG; Löffler BM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):871-7. PubMed ID: 9396733
[TBL] [Abstract][Full Text] [Related]
15. Expression of human endothelin-converting enzyme isoforms: role of angiotensin II.
Goettsch W; Schubert A; Morawietz H
Can J Physiol Pharmacol; 2008 Jun; 86(6):299-309. PubMed ID: 18516092
[TBL] [Abstract][Full Text] [Related]
16. Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2.
Davenport AP; Kuc RE
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S12-4. PubMed ID: 11078322
[TBL] [Abstract][Full Text] [Related]
17. Protein Kinase C recognition sites in the cytoplasmic domain of Endothelin Converting Enzyme-1c.
Kuruppu S; Tochon-Danguy N; Smith AI
Biochem Biophys Res Commun; 2012 Oct; 427(3):606-10. PubMed ID: 23022525
[TBL] [Abstract][Full Text] [Related]
18. Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.
Brooks SC; Fernandez L; Ergul A
Mol Cell Biochem; 2000 May; 208(1-2):45-51. PubMed ID: 10939627
[TBL] [Abstract][Full Text] [Related]
19. The expression of endothelin-1 and endothelin-converting enzyme-1 (ECE-1) are independently regulated in bovine aortic endothelial cells.
Corder R; Barker S
J Cardiovasc Pharmacol; 1999 Apr; 33(4):671-7. PubMed ID: 10218741
[TBL] [Abstract][Full Text] [Related]
20. ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms.
Whyteside AR; Hinsley EE; Lambert LA; McDermott PJ; Turner AJ
Can J Physiol Pharmacol; 2010 Aug; 88(8):850-4. PubMed ID: 20725143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
